-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Maintains Buy on Orchestra BioMed Hldgs, Lowers Price Target to $10

Benzinga·05/19/2026 19:44:08
Listen to the news
B. Riley Securities analyst Kyle Bauser maintains Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Buy and lowers the price target from $12 to $10.